Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromes

British Journal of Haematology

Volumn 103, Issue 3, 1998, Pages 778-784

  Tamura, H ^a   Ogata, K ^a   Luo, S ^a   Nakamura, K ^a   Yokose, N ^a   Dan, K ^a   Tohyama, K ^b   Yoshida, Y ^b   Hamaguchi, H ^c   Sakamaki, H ^d   Kuwaki, T ^e   Tahara, T ^e   Kato, T ^e   Nomura, T ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c MUSASHINO RED CROSS HOSPITAL   (Japan)

^d TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^e KIRIN BREWERY CO LTD   (Japan)

Author keywords

Myelodysplastic syndromes; Thrombopoietin; Thrombopoietin receptor

Indexed keywords

THROMBOPOIETIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REFRACTORY ANEMIA; THROMBOCYTE; THROMBOCYTOPENIA;

BLOOD PLATELETS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CYTOKINE; RECEPTORS, THROMBOPOIETIN; THROMBOPOIETIN;

EID: 7844249790     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01054.x     Document Type: Article

References (38)

1. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
2. Bouscary, D., Preudhomme, C., Ribrag, V., Melle, J., Viguie, F., Picard, F., Guesnu, M., Fenaux, P., Gisselbrecht, S. & Dreyfus, F. (1995) Prognostic value of c-mpl expression in myelodysplastic syndromes. Leukemia, 9, 783-788.
3. Broudy, V.C., Lin, N.L., Sabath, D.F., Papayannopoulou, T. & Kaushansky, K. (1997) Human platelets display high-affinity receptors for thrombopoietin. Blood, 89, 1896-1904.
4. Cohen-Solal, K., Villeval, J., Titeux, M., Lok, S., Vainchenker, W. & Wendling, F. (1996) Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis. Blood, 88, 2578-2584.
5. Dacie, J.V., Smith, M.D., White, J.C. & Mollin, D.L. (1959) Refractory normoblastic anaemia: a clinical and haematological study of seven cases. British Journal of Haematology, 5, 56-62.
6. Debili, N., Wendling, F., Cosman, D., Titeux, M., Florindo, C., Dusanter, F.I., Schooley, K., Methia, N., Charon, M., Nador, R., Bettaieb, A. & Vainchenker, W. (1995a) The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood, 85, 391-401.
7. Debili, N., Wendling, F., Katz, A., Guichard, J., Breton, G.J., Hunt, P. & Vainchenker, W. (1995b) The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood, 86, 2516-2525.
8. Duhrsen, U. & Hossfeld, D.K. (1996) Stromal abnormalities in neoplastic bone marrow diseases. Annals of Hematology, 73, 53-70.
9. Emmons, R.V., Reid, D.M., Cohen, R.L., Meng, G., Young, N.S., Dunbar, C.F., & Shulman, N.R. (1996) Human thrombopoietin leels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood, 87, 4068-4071.
10. Fielder, P.J., Hass, P., Nagel, M., Stefanich, E., Widmer, R., Bennett, G.L., Keller, G.A. & Eaton, D. (1997) Human platelets as a model for the binding and degradation of thrombopoietin. Blood, 89, 2782-2788.
11. Hofmann, W.K., Ottmann, O.G., Ganser, A. & Hoelzer, D. (1996) Myelodysplastic syndromes: clinical features. Seminars in Hematology, 33, 177-185.
12. Ishida, A., Miyakawa, Y., Tanosaki, R., Wakui, M., Ueno, H., Watanabe, R., Awaya, N., Tahara, T., Kato, T., Miyazaki, H., Oda, A., Kizaki, M., Okamoto, S. & Ikeda, Y. (1996) Circulating endogenous thrombopoietin, interleukin-3, interleukin-6 and interleukin-11 levels in patients undergoing allogeneic bone marrow transplantation. International Journal of Heamatology, 65, 61-69.
13. Kaushansky, K. (1995) Thrombopoietin: the primary regulator of platelet production. Blood, 86, 419-431.
14. Kojima, S., Matsuyama, T., Kodera, Y., Tahara, T. & Kato, T. (1997) Measurement of endogenous plasma thrombopoietin in patients with acquired aplastic anaemia by a sensitive enzyme-linked immunosorbent assay. British Journal of Haematology, 97, 538-543.
15. Kunishima, S., Tahara, T., Kato, T., Kobayashi, S., Saito, H. & Naoe, T. (1996) Serum thrombopoietin and plasma glycocalicin concentrations as useful diagnostic markers in thrombocytopenic disorders. European Journal of Haematology, 57, 68-71.
16. Kuter, D.J., Beeler, D.L. & Rosenberg, R.D. (1994) The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proceedings of the National Academy of Sciences of the United States of America, 91, 11104-11108.
17. Kuter, D.J. & Rosenberg, R.D. (1995) The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood, 85, 2720-2730.
18. Kuwaki, T., Hagiwara, T., Yuki, C., Kodama, I., Kato, T. & Miyazaki, H. (1998) Quantitative analysis of thrombopoietin receptors on human megakaryocytes. FEBS Letters, 427, 46-50.
19. McCarty, J.M., Sprugel, K.H., Fox, N.E., Sabath, D.E. & Kaushansky, K. (1995) Murine thrombopoietin in RNA levels are modulated by platelet count. Blood, 86, 3668-3675.
20. Meng, Y.G., Martin, T.G., Peterson, M.L., Shuman, M.A., Cohen, R.L. & Wong, W.L. (1996) Circulating thrombopoietin concentrations in thrombocytopenic patients, including cancer patients following chemotherapy, with or without peripheral blood progenitor cell transplantation. British Journal of Haematology, 95, 535-541.
21. Morita, H., Tahara, T., Matsumoto, A., Kato, T., Miyazaki, H. & Ohashi, H. (1996) Functional analysis of the cytoplasmic domain of the human Mpl receptor for tyrosine-phosphorylation of the signaling molecules, proliferation and differentiation. FEBS Letters, 395, 228-234.
22. Negrin, R.S., Haeuber, D.H., Nagler, A., Kobayashi, Y., Sklar, J., Donlon, T., Vincent, M. & Greenberg, P.L. (1990) Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood, 76, 36-43.
23. Ogata, K., Fujii, H., Yokose, N., An, E., Tamura, H., Kamikubo, K., Dan, K., Hamaguchi, H., Sakamaki, H., Onozawa, Y. & Nomura, T. (1994) Defective natural killer (NK) cell-mediated cytotoxicity does not imply clonal involvement of NK cells in myelodysplastic syndromes. British Journal of Haematology, 87, 396-398.
24. + cells. Cancer Research, 57, 5037-5040.
25. Prchal, J.T., Throckmorton, D.W., Carroll, A.D., Fuson, E.W., Gams, R.A. & Prchal, J.F. (1978) A common progenitor for human myeloid and lymphoid cells. Nature, 274, 590-591.
26. Raskind, W.H., Tirumali, N., Jacobson, R., Singer, J. & Fialkow, P.J. (1984) Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood, 63, 1318-1323.
27. Rose, E.H., Abels, R.I., Nelson, R.A., McCullough, D.M. & Lessin, L. (1995) The use of r-HuEpo in the treatment of anaemia related to myelodysplasia (MDS). British Journal of Haematology, 89, 831-837.
28. Stoffel, R., Wiestner, A. & Skoda, R.C. (1996) Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood, 87, 567-573.
29. Sungaran, R., Markovic, B. & Chong, B.H. (1997) Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood, 89, 101-107.
30. Tahara, T., Usuki, K., Sato, H., Ohashi, H., Morita, H., Tsumura, H., Matsumoto, A., Miyazaki, H., Urabe, A. & Kato, T. (1996) A sensitive sandwich KLISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders. British Journal of Haematology, 93, 783-788.
31. Takeshita, A., Shinjo, K., Naito, K., Nakamura, S., Izumi, M., Ling, P., Ohnishi, K. & Ohno, R. (1997) Amount of mpl on bone marrow haemopoietic precursor cells from healthy volunteers and patients with refractory anaemia. British Journal of Heamatology, 99, 746-755.
32. Tamura, H., Ogata, K., Dan, K. & Nomura, T. (1997) Rationale and hematologic target points in response-oriented individualized induction chemotherapy for acute myeloid leukemia. International Journal of Heamatology, 66, 325-334.
33. Tefferi, A., Thibodeau, S.N. & Solberg, L.J. (1990) Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. Blood, 75, 1770-1773.
34. Usuki, K., Tahara, T., Iki, S., Endo, M., Osawa, M., Kitazume, K., Kato, T., Miyazaki, H. & Urabe, A. (1996) Serum thrombopoietin level in various hematological diseases. Stem Cells, 14, 558-565.
35. Verhoef, G.E., De, S.P., Ceuppens, J.L., Van, D.J., Goossens, W. & Boogaerts, M.A. (1992) Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia, 6, 1268-1272.
36. Walker, F., Nicola, N.A., Metcalf, D. & Burgess, A.W. (1985) Hierarchical down-modulation of hemopoietic growth factor receptors. Cell, 43, 269-276.
37. Yokose, N., Ogata, K., An, E., Tamura, H., Kamikubo, K., Dan, K. & Nomura, T. (1995) Lineage-unrestricted hematologic response to granulocyte colony-stimulating factor in a patient with refractory anemia with excess blasts. Annals of Hematology, 70, 163-167.
38. Zwierzina, H., Rollingerholzinger, I., Nuessler, V., Herold, M. & Meng, Y.G. (1998) Endogenous serum thrombopoietin concentrations in patients with myelodysplastic syndromes. Leukemia, 12, 59-64.